Vext ScienceVEXTF 71 OCF Margin % is 13.28% as of Mar. 2026, which is 4% above its 10-year median of 12.71. GuruFocus rates VEXTF with a GF Score™ of 71/100 and a GF Value™ of $1.08 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 963 Drug Manufacturers companies, Vext Science ranks better than 77.05% on this metric.
The historical rank and industry rank for Vext Science's OCF Margin % or its related term are showing as below:
VEXTF'
s OCF Margin % Range Over the Past 10 Years
Min: -1.76 Med: 12.71 Max: 30.23
Current: 19.72
During the past 9 years, the highest OCF Margin % of Vext Science was 30.23%. The lowest was -1.76%. And the median was 12.71%.
VEXTF's OCF Margin % is ranked better than 77.05% of 963
companies
in the Drug Manufacturers industry
Industry Median: 9.95
vs VEXTF: 19.72
Vext Science OCF Margin % Related Terms
Vext Science OCF Margin % Historical Data
* Premium members only.
The historical data trend for Vext Science's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Vext Science's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vext Science OCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Vext Science's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Vext Science's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vext Science (VEXTF) has a OCF Margin % of 13.28% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Vext Science and its competitors. This is near median its historical median of 12.71. According to the industry distribution chart, Vext Science ranks #221 out of 963 companies in the Drug Manufacturers industry, placing it in the top 22.9%.
Is Vext Science's OCF Margin % too high?
Vext Science's current OCF Margin % of 13.28% is near median its 10-year median of 12.71. The Drug Manufacturers industry median OCF Margin % is 9.95. Vext Science's value of 13.28% is 33.5% above this industry median. Based on the distribution chart, Vext Science ranks #221 out of 963 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Vext Science has a GF Score™ of 71/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Vext Science's OCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Vext Science ranks #221 out of 963 companies for OCF Margin %. This places Vext Science in the top 23% of its industry — outperforming the majority of peers. The industry median OCF Margin % is 9.95. Vext Science's value of 13.28% is 33.5% above this benchmark. While the company's 10-year median is 12.71 vs. the industry median of 9.95, Vext Science has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 9.95, based on 963 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vext Science's current OCF Margin % of 13.28% is 33.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Vext Science and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 9.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vext Science's current OCF Margin % is 13.28%, which is near median its own 10-year median of 12.71. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vext Science stock overvalued right now?
Based on GuruFocus' analysis, Vext Science (VEXTF) is currently considered Possible Value Trap. The stock's GF Value™ is $1.08, compared to a current price of $0.16 — trading 84.9% below its estimated fair value. The current OCF Margin % is 13.28%, which is near median its 10-year median of 12.71 and 33.5% above the Drug Manufacturers industry median of 9.95. Vext Science's overall GF Score™ is 71/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Vext Science (VEXTF), the current OCF Margin % is 13.28% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vext Science (VEXTF) Overvalued in 2026?
Based on GuruFocus' analysis, Vext Science stock appears to be undervalued.
The current stock price of $0.16 is trading 84.9% below its estimated GF Value™ of $1.08.
GuruFocus considers Vext Science to be Possible Value Trap.
Key valuation signals for VEXTF:
OCF Margin %: 13.28% (near median its 10-year median of 12.71)
GF Value™: $1.08 vs. price of $0.16 (84.9% below fair value)
Industry Position: 33.5% above the Drug Manufacturers median (#221 of 963)
No single metric tells the full story. See the VEXTF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vext Science Inc engages in the full spectrum of the cannabis product lifecycle, from development and manufacturing to distribution. Its brands include Herbal Wellness, Appalachian Pharm, Revibe, Prism, Vapen, and Firebrand. In Arizona and Ohio, the dispensaries operate under the Herbal Wellness Center brand, while in Ohio the cultivation and manufacturing operations are licensed and branded as Appalachian Pharms Cultivation and Appalachian Pharm Processing. The Company operates through a single operating segment engaged in the cultivation, manufacturing, distribution, and sale of cannabis within the United States. All revenues are generated in the United States.
71GF Score
Get the complete analysis for VEXTF
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
VEXTF has been successfully added to your 
